Definitive Diagnosis of Inflammatory Breast Cancer
The definitive diagnosis of inflammatory breast cancer (IBC) requires pathological confirmation of invasive carcinoma from a core biopsy, with the finding of tumor emboli in dermal lymphatics (dermal lymphatic invasion or DLI) being pathognomonic when present, though it is not required for diagnosis as it is found in less than 75% of IBC cases. 1
Diagnostic Criteria
- IBC diagnosis is primarily clinical with essential pathological confirmation of invasive carcinoma 1
- Clinical criteria include:
Pathological Features
- Dermal lymphovascular tumor emboli (option B in the question) are considered the histological hallmark of IBC 1
- When present in skin punch biopsy, dermal lymphatic invasion (DLI) is pathognomonic for IBC 1, 2
- DLI presents as dilated dermal lymphovascular spaces filled with tumor emboli that are often retracted away from the surrounding endothelial lining 1
- Despite being pathognomonic, DLI is identified in less than 75% of patients with IBC, making it not an absolute requirement for diagnosis 1
Role of Imaging in Diagnosis
- Mammography and other radiological investigations are recommended as part of staging work-up, not for primary diagnosis 1
- Current evidence is insufficient to define any radiological signs specific for IBC 1
- The "unique mammographic appearance" (option A in the question) is not considered diagnostic for IBC 1
Role of Inflammatory Cell Infiltration
- Finding extensive inflammatory cell infiltration of the tumor (option C in the question) is not mentioned as a diagnostic criterion in current guidelines 1
- IBC is not defined by inflammatory cells within the tumor itself, but rather by the clinical presentation and the presence of tumor emboli in dermal lymphatics 1, 2
Recommended Diagnostic Approach
- Core biopsy to confirm invasive carcinoma is required 1
- At least two skin punch biopsies are strongly recommended for patients who meet the clinical diagnostic criteria 1
- The best area to sample is the most prominent area of skin discoloration 1
- All IBC tumors should be tested for hormone receptors and HER2 status 1
Common Pitfalls in Diagnosis
- Relying solely on imaging findings without clinical correlation may lead to missed diagnoses 1
- Failure to perform skin punch biopsies may miss the opportunity to identify pathognomonic dermal lymphatic invasion 1
- Waiting for response to antibiotics may delay diagnosis 1
- Misdiagnosis as mastitis or generalized dermatitis is common due to the rarity of IBC 3